Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Linda Mancione"'
Autor:
Stephen L Hauser, Anne H Cross, Kevin Winthrop, Heinz Wiendl, Jacqueline Nicholas, Sven G Meuth, Paul S Giacomini, Francesco Saccà, Linda Mancione, Ronald Zielman, Morten Bagger, Ayan Das Gupta, Dieter A Häring, Valentine Jehl, Bernd C Kieseier, Ratnakar Pingili, Dee Stoneman, Wendy Su, Roman Willi, Ludwig Kappos
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England), vol 28, iss 10
Background: Ofatumumab is approved for the treatment of relapsing multiple sclerosis (RMS). Ongoing safety reporting is crucial to understand its long-term benefit–risk profile. Objective: Report the safety and tolerability of ofatumumab in RMS aft
Autor:
Jackie Han, Seung Bong Hong, Linda Mancione, Christian Brandt, Christian E. Elger, Christine Strohmaier
Publikováno v:
Epilepsia. 58:1217-1226
SummaryObjectives To evaluate dose–response relationship of BGG492 as add-on therapy to 1–3 antiepileptic drugs in patients with partial-onset seizures and to investigate safety and tolerability of BGG492. Methods This was a 12-week, randomized,
Autor:
Domenico Inzitari, Jean Marc Orgogozo, Howard Feldman, Teodoro Del Ser, Steven G. Potkin, Steven H. Ferris, Heinrich Sauer, Jeffrey L. Cummings, Sibel Tekin, Martin R. Farlow, Elio Scarpini, Linda Mancione, Philip Scheltens, H. Cecil Charles, Yunsheng He, Alistair Burns, Nathan Herrmann, Nikolaos Sfikas, Bengt Winblad, Roger Lane, Nick C. Fox
Publikováno v:
Feldman, H H, Ferris, S, Winblad, B, Sfikas, N, Mancione, L, He, Y, Tekin, S, Burns, A, Cummings, J, del Ser, T, Inzitari, D, Orgogozo, J M, Sauer, H, Scheltens, P, Scarpini, E, Herrmann, N, Farlow, M, Potkin, S, Charles, H C, Fox, N C & Lane, R 2007, ' Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment : the InDDEx study ', Lancet Neurology, vol. 6, no. 6, pp. 501-512 . https://doi.org/10.1016/S1474-4422(07)70109-6
Lancet Neurology, 6(6), 501-512. Lancet Publishing Group
Lancet Neurology, 6(6), 501-512. Lancet Publishing Group
Summary Objective To assess the effect of rivastigmine in patients with mild cognitive impairment (MCI) on the time to clinical diagnosis of Alzheimer's disease (AD) and the rate of cognitive decline. Methods The study was a double-blind, randomised,
Autor:
Sibel Tekin, Ph. Scheltens, Howard Feldman, P. Mesenbrink, Roger Lane, Elio Scarpini, N. Hermann, Steven H. Ferris, Linda Mancione
Publikováno v:
Neurology, 62(7), 1199-1201. Lippincott Williams and Wilkins
Scopus-Elsevier
ResearcherID
Feldman, H, Scheltens, P, Scarpini, E, Hermann, N, Mesenbrink, P, Mancione, L, Tekin, S, Lane, R & Ferris, S 2004, ' Behavioral symptoms in mild cognitive impairment ', Neurology, vol. 62, no. 7, pp. 1199-1201 . https://doi.org/10.1212/01.WNL.0000118301.92105.EE
Scopus-Elsevier
ResearcherID
Feldman, H, Scheltens, P, Scarpini, E, Hermann, N, Mesenbrink, P, Mancione, L, Tekin, S, Lane, R & Ferris, S 2004, ' Behavioral symptoms in mild cognitive impairment ', Neurology, vol. 62, no. 7, pp. 1199-1201 . https://doi.org/10.1212/01.WNL.0000118301.92105.EE
The authors investigated neuropsychiatric symptoms in mild cognitive impairment (MCI) from baseline data of the Investigation in the Delay to Diagnosis of AD with Exelon (InDDEx) study (n = 1,010). Neuropsychiatric symptoms were reported in 59% of su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab9c69aa896e485d0f83eea66a6b388f
https://research.vumc.nl/en/publications/16df9361-8bcd-4a3a-aaad-943f9892f528
https://research.vumc.nl/en/publications/16df9361-8bcd-4a3a-aaad-943f9892f528
Publikováno v:
Neurobiology of Aging. 25:S472
Autor:
Peter J. Weiden, Linda Mancione, Mallery G. Mayo, Curt D. Wolfgang, Guangyang Han, Saeed Ahmed, Raymond Manning, J. Michael Ryan
Publikováno v:
CNS Drugs
Background The purpose of this study was to evaluate the safety and effectiveness of iloperidone for the prevention of relapse in schizophrenia. Methods Study subjects were adults with schizophrenia who started on oral open-label iloperidone titrated